U.S. Markets open in 3 hrs 49 mins

(PCYC)


NasdaqGS . Currency in USD
Add to watchlist
Full screen
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals3 months ago

    Forbes: Eight of the world’s billionaires call Tampa Bay home

    Shopping center magnate Edward DeBartolo Jr. continues to top the list of Tampa Bay’s wealthiest people. DeBartolo, with a net worth of $2.9 billion as of March 19, ranked No. 693 on Forbes’ new list of the world’s billionaires . DeBartolo, a former owner of the San Francisco 49ers, is founder and CEO of DeBartolo Holdings in Tampa.

  • American City Business Journals4 months ago

    Here’s where a Pinellas billionaire and top donor to Church of Scientology is putting his investment dollars

    Robert Duggan, one of the most influential executives in the biopharmaceutical field, has bought a 15.4 percent stake in Pulse Biosciences Inc., a Burlingame, California medical technology company. Duggan, who relocated to the Tampa Bay area after selling biotech firm Pharmacyclics to AbbVie in May 2015 for $21 billion, controls nearly 2.2 million shares of Pulse Biosciences (PLSE), with most of the stock purchased between Dec. 7 and Feb. 9, a Feb. 21 filing with the U.S. Securities and Exchange Commission said. Duggan has a net worth of $2.6 billion, according to Forbes, which included him on the 2016 list of the 400 wealthiest people in the United States.

  • American City Business Journals4 months ago

    These drug and medical device companies made the most payments to Chicago hospitals

    Drug company Pharmacyclics made the highest amount of non-research payments out of the more than $9 million in payments received by 25 Chicago-area doctors in 2015. Sunnyvale, California-based Pharmacyclics, ...